HQ Function

Previously served as the primary center for research and development, clinical operations, and corporate administration. Currently supports significantly reduced operations focused on exploring strategic alternatives and managing residual obligations.

Notable Features:

Modern laboratory and office facilities designed to support virology research and drug development, situated within a prominent Southern California biotech cluster. Specific architectural highlights are not publicly detailed.

Work Culture:

Previously characterized by a fast-paced, innovative, and collaborative environment typical of a clinical-stage biotech focused on urgent global health needs. Post-restructuring, the culture is one of transition, managed by a smaller team focused on strategic outcomes.

HQ Significance:

The headquarters was the nerve center for Pardes Biosciences' ambitious program to develop a novel oral antiviral for COVID-19 and other viral threats, representing its core scientific and operational capabilities.

Values Reflected in HQ: Prior to its strategic shift, the headquarters likely embodied values such as scientific excellence, urgency in addressing health crises, innovation, and collaboration. Currently, it reflects prudent capital management and strategic focus.

Location:

While headquartered in the United States, Pardes Biosciences's mission to develop antiviral therapeutics for global health threats like COVID-19 inherently had a global outlook. Its clinical development programs, when active, would have involved trial sites and collaborations potentially spanning multiple countries. Post-restructuring, its direct global operational footprint is minimal, with activities focused on managing prior commitments and exploring strategic alternatives that may have international implications.

Street Address:

2175 Faraday Ave, Suite 280

City:

Carlsbad

State/Province:

California

Country:

USA